R10

R10 is a next-generation investigational peptide that targets GLP-1, GIP, and glucagon receptors simultaneously. This triple-agonist design makes it one of the most potent metabolic-modulating compounds in development. In research settings, it has been shown to significantly influence appetite regulation, energy expenditure, glucose control, and body-fat reduction far more aggressively than earlier single- or dual-agonists.

Dominus Research Labs – Terms & Conditions

All products sold are research compounds for laboratory use only and not intended for human or animal consumption. Purchasers must be 18 years or older. By purchasing, buyer assumes all responsibility and liability for use, handling, storage, and compliance with applicable laws. No medical claims are made or implied. All sales are final. Dominus Research Labs is not responsible for products once delivered in good condition and assumes no liability for misuse or damages arising from purchase or use.